The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Ekman Lars since year 2005.
The trader's CIK number is 1376117.
At the time of the last reporting, Ekman Lars was the Director of Amarin Corp Plc\uk .
(stock ticker symbol AMRN).
See this page for all insider trading activities at Amarin Corp Plc\uk .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-09-03||AMRN||Amarin Corp Plc\\uk||Option Ex||91,016||3.95||359,513|
|2019-09-03||AMRN||Amarin Corp Plc\\uk||Sale||91,016||15.01||1,365,695|
|2019-05-30||ONCE||Spark Therapeutics, Inc.||Option Ex||1,500||.00||0|
|2019-03-04||AMRN||Amarin Corp Plc\\uk||Option Ex||135,377||1.99||269,806|
|2019-03-04||AMRN||Amarin Corp Plc\\uk||Sale||135,377||21.44||2,901,941|
|2019-01-10||AMRN||Amarin Corp Plc\\uk||Option Ex||100,416||1.03||103,428|
|2019-01-10||AMRN||Amarin Corp Plc\\uk||Sale||140,416||16.99||2,385,948|
|2018-05-31||ONCE||Spark Therapeutics, Inc.||Option Ex||1,500||.00||0|
|2015-11-25||PRTA||Prothena Corp Plc||Sale||30,000||73.71||2,211,210|
|2015-11-25||PRTA||Prothena Corp Plc||Option Ex||30,000||6.41||192,300|
|2014-12-18||SPHS||Sophiris Bio Inc.||Sale||9,663||.47||4,541|
|2014-05-30||ITMN||Intermune Inc||Option Ex||3,000||.00||0|
|2013-11-20||AMRN||Amarin Corp Plc\\uk||Buy||40,000||1.80||72,000|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ekman Lars (Director of Amarin Corp Plc\uk at the time of this reporting) see the Securities and Exchange Commission (SEC) website.